New NO-Donors with antithrombotic and vasodilating activities, part 17. Arylazoamidoximes and 3-arylazo-1,2,4-oxadiazol-5-ones

Archiv der Pharmazie

Volumn 330, Issue 12, 1997, Pages 392-398

  Rehse, Klaus ^a   Bade, Stephan ^a   Harsdorf, Angela ^b   Clement, Bernd ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

1,2,4 oxadiazol 5 ones; Antithrombotic properties; Azoamidoximes; Decreased blood pressure; Nitric oxide formation; Platelet inhibition

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; ANTITHROMBOCYTIC AGENT; MINOXIDIL; NITRIC OXIDE; OXIME DERIVATIVE; OXYHEMOGLOBIN; PHENYLAZOMETHANEAMIDOXIME; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HYPERTENSION; IN VITRO STUDY; MALE; MASS SPECTROMETRY; MICROSOME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; SPECTROSCOPY; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; VENULE;

ANIMALS; BLOOD PRESSURE; FIBRINOLYTIC AGENTS; HUMANS; NITRIC OXIDE; OXADIAZOLES; OXIMES; PLATELET AGGREGATION INHIBITORS; RATS; RATS, INBRED SHR; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 0031468133     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19973301207     Document Type: Article

References (22)

1. D.J. Stuehr, N.S. Kwon, C.F. Nathan, O.W. Griffith, P.L. Feldmann, J. Wiseman, J. Biol. Chem. 1991, 226, 6259-6263.
2. B. Clement, M.H. Schultze-Mosgau, H. Wohlers, Biochem. Pharmacol. 1993, 46, 2249-2267.
3. V. Andronik-Lion, J.L. Boucher, M. Delaforge, Y. Henry, D. Mansuy, Biochem. Biophys. Rev. Commun. 1992, 185, 452-458.
4. D. Mansuy, J.L. Boucher, B. Clement. Biochimie 1995, 77, 661-667.
5. G. Longo, Gazz. Chim. Ital. 1933, 63, 923-926.
6. J.A. Maddison, P.W. Seale, E.P. Tiley, W.K. Warburton, J. Chem. Soc. Perkin Trans. 1 1974, 81-85.
7. J. Armand, C.R. Acad. Sci. Ser C. 1966, 262, 592-595.
8. K. Rehse, K.-J. Schleifer, T. Ciborski, H. Bohn, Arch. Pharm. (Weinheim) 1993, 326, 791-797.
9. K. Rehse, A. Kesselhut, V. Schein, M. Kämpfe, B. Rose, E. Unsöld, Arch. Pharm. (Weinheim) 1991, 324, 301-305.
10. B. Clement, S. Schmitt, M. Zimmermann, Arch. Pharm. (Weinheim), 1988, 321, 955-956.
11. B. Clement, F. Jung, Drug Metab. Dispos. 1994, 22, 486-497.
12. B. Clement, M. Immel, S. Schmitt, U Steinmann. Arch. Pharm. (Weinheim) 1993, 326, 807-812.
13. K. Rehse, M. Herpel, D. Piechocki. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 83-86.
14. H.-J. Duchstein, S. Riederer, Arch. Pharm. (Weinheim) 1995, 328, 317-324.
15. J. Capdevila, Y. Sacki, J. R. Falck, Xenobiotica 1984, 14, 105-118.
16. A. K. Cho, J. D. Duncan, J. M. Fukuto in N-Oxidations of drugs: Biochemistry, Pharmacology, Toxicology (Ed.: P. Hlavica, L. A. Damani), Chapman and Hall, London, 1991, pp. 207-215.
17. B. Clement, M. H. Schultze-Mosgau, H. Wohlers, F. Jung in Biology of nitric oxide ptl (Ed.: M. Feelisch, R. Busse, S. Moncada), Portland Press, London, 1995, pp. 15-20.
18. K. Rehse, R. Nolte-Driller. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 191-196.
19. M. Feelisch, D. Kubitzek, J. Werringloer. Methods in Nutric Oxide Research, (Ed. M. Feelisch, J. Stamler), J. Wiley, and Sons, Chichester. New York, Brisbane, Toronto, Singapore, 1996, pp. 455-478
20. T. Omuro, R. Sato, J. Biol. Chem. 1964, 239, 2370-2378.
21. A. G. Gornall, C. J. Bardawill, M. M. Davd, J. Biol. Chem. 1949, 177, 751-766.
22. M. Feelisch, E. Noack, Biochem. Biophys. Res. Commun. 1988, 154, 236-244.